MSK-ACCESS powered with SOPHiA DDM - Brochure
Push the boundaries of your in-house liquid biopsy capabilities with MSK-ACCESS® powered with SOPHiA DDM™, a decentralized version of the rigorously validated cell-free DNA (cfDNA) assay developed and regularly used in clinical routine by Memorial Sloan Kettering Cancer Center (MSK)1,2.
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.